• News and Press

The Latest News and Stories Related to the QuintilesIMS Institute

Global Cancer Drug Spending to Exceed $150 Billion by 2020: IMS Report


Worldwide spending on cancer medicines will exceed $150 billion by 2020, driven by the emergence of expensive new therapies that help the immune system to attack tumors, according to a global oncology report released by IMS Health Holdings on Thursday.

The World Spent This Much on Cancer Drugs Last Year


Spending on cancer medicines totaled $107 billion worldwide in 2015 and is projected to exceed $150 billion by 2020, reflecting adoption of newer, pricier therapies, according to a report from the IMS Institute for Healthcare Informatics.

We’re spending $107 billion on cancer drugs, but is it worth it?


Washington Post
A flood of innovative cancer treatments helped fuel an 11.5 percent surge in spending on oncology drugs over the past year -- to $107 billion globally, according to a new report. But there's a crucial question the study can't quite answer: How much are patients benefiting from this expanding arsenal of high-priced drugs?

The Ever-Escalating Cost Of Cancer Drugs


CBS MoneyWatch
The total cost of oncology drugs and supportive care medications surged 11.5 percent in 2015 to reach $107 billion globally, according to a new study from IMS Institute for Healthcare Informatics. The spending is based on invoice prices, the amount hospitals or pharmacies paid to distributors.

See More

To learn more about ways that the QuintilesIMS Institute can support your initiatives, please reach out to our team: